How can we change the perception of psychedelic medicine and use them to treat some of the word’s biggest central nervous system problems?  

The next generation of central nervous system drugs inspired by psychedelic medicines. Gilgamesh is a serious mental health science-focused, preclinical biotechnology company, with a focus on developing innovative new chemical entities (NCE’s) leveraging a unique combination of medicinal chemistry, intellectual property strategy, neuroscience & neurobiology, and drug development expertise.

“Novel Psychotropic Drugs for the Treatment of Neuropsychiatric conditions including depression, anxiety, substance use, and stress-related disorders.”